首页> 外文期刊>World Journal of Gastroenterology >Infliximab induces remission in cryptogenic multifocal ulcerous stenosing enteritis: First case
【24h】

Infliximab induces remission in cryptogenic multifocal ulcerous stenosing enteritis: First case

机译:英夫利昔单抗诱导隐源性多灶性溃疡性狭窄性肠炎的缓解:第一例

获取原文
获取外文期刊封面目录资料

摘要

We present the case of a 29-year-old patient with a history of abdominal pain and vomiting. Based on wireless video capsule findings he was previously diagnosed with ileal Crohn’s disease at a different institution, although the clinical and radiological picture was not typical and the response to corticosteroids was poor. We performed a single-balloon enteroscopy showing a short, ulcerous stenosis 50 cm proximal from Bauhin’s valve. The endoscopic and clinical histopathological findings were compatible with cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). High dose corticosteroids were again started, without effect. The monoclonal tumor necrosis factor-α (TNF-α) antibody infliximab was added to the medical therapy. After induction therapy, both clinical and endoscopic amelioration was obtained. Larger case studies are needed to confirm the efficacy of TNF-α inhibition in steroid refractory CMUSE.
机译:我们介绍了一例有腹痛和呕吐史的29岁患者。根据无线视频胶囊的发现,尽管临床和影像学检查并不典型,对皮质类固醇的反应较差,但他先前曾在其他机构被诊断出患有回肠克罗恩氏病。我们进行了单气囊肠镜检查,显示在Bauhin瓣膜近侧50 cm处发生了短暂的溃疡性狭窄。内窥镜检查和临床组织病理学发现与隐源性多灶性溃疡性狭窄性肠炎(CMUSE)相容。再次开始使用大剂量皮质类固醇,但没有效果。将单克隆肿瘤坏死因子-α(TNF-α)抗体英夫利昔单抗加入药物治疗。诱导治疗后,临床和内镜均得到改善。需要更大的案例研究来证实在类固醇难治性CMUSE中抑制TNF-α的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号